Page last updated: 2024-11-03

risperidone and Neoplasms, Neuroepithelial

risperidone has been researched along with Neoplasms, Neuroepithelial in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Neoplasms, Neuroepithelial: Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zugman, A1
Pan, PM1
Gadelha, A1
Mansur, RB1
Asevedo, E1
Cunha, GR1
Silva, PF1
Brietzke, E1
Bressan, RA1

Other Studies

1 other study available for risperidone and Neoplasms, Neuroepithelial

ArticleYear
Brain tumor in a patient with attenuated psychosis syndrome.
    Schizophrenia research, 2013, Volume: 144, Issue:1-3

    Topics: Adolescent; Antipsychotic Agents; Brain Neoplasms; Cognitive Behavioral Therapy; Combined Modality T

2013